20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ES-ZOPICLONE USP, with a corresponding US DMF Number 26164.
Remarkably, this DMF maintains an Active status since its submission on June 07, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 06, 2018, and payment made on September 05, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II